All News

A review provided latest updates in type 1 narcolepsy, particularly sleepiness-related implications and the role of immune, genetic, and epidemiological aspects.

Hydroxychloroquine (HCQ) does not prevent coronavirus disease 2019 (COVID-19), according to a new study, and The Lancet retracted a previous paper examining the drug's safety; voters are mainly split along party lines when it comes to in-person voting in a pandemic; ownership of a handgun is associated with a significantly greater risk of suicide by firearm.

Despite a decline in deaths from coronary heart disease (CHD) in the United States over the past 40 years, CHD is still the top cause of mortality in the United States—especially in low-income counties.

Researchers created a test to determine which children with Carbamoyl-Phosphate Synthetase 2, Aspartate Transcarbamylase, And Dihydroorotase (CAD) gene deficiency will benefit from receiving a nutritional supplement previously deemed effective in children with the condition, according to a study published in Genetics in Medicine.

Based on findings of a study conducted by the Michael J. Fox Foundation for Parkinson Research, the individual annual economic burden for a patient with Parkinson disease amounted to $52,000 in 2017, with nonacute institutional care, inpatient hospitalization, and outpatient care indicated as the largest drivers of cost among differing coverage plans.

There was a 6% increase from 2005 to 2014 in new HIV diagnoses among gay, bisexual, and other men who have sex with men, according to the CDC and study results published in Journal of Epidemiology and Community Health, and 1 in 6 is estimated to test positive for the disease at some point in his lifetime.

CMS Administrator Seema Verma announced the update today in a blog post in Health Affairs.

Microperimetric mean sensitivity and deep scotoma points may be useful end points for clinical trials investigating emerging treatments for Stargardt disease, according to a study published in JAMA Ophthalmology.

New therapies for autoimmune conditions like rheumatoid arthritis (RA) highlight the potential of metabolic targets. A recent study highlights some of the most promising targets.

Because of the coronavirus disease 2019 (COVID-19) pandemic, the FDA was forced to delay updated food safety tracing guidelines; the Government Accountability Office is not happy with the current safety of the US drug supply chain; House committee chairs are seeking more details on the government’s COVID-19 vaccine contracts with drug makers.

A global epidemiological study on psoriasis has found that the prevalence, incidence, and burden of suffering caused by the disease has risen over the last 3 decades.

Older age was shown to influence the decision among women to undergo surgery as a treatment option following a diagnosis of breast cancer in the United Kingdom, where the average lifespan was 82.9 years in 2016.

Bristol Myers Squibb announced the commercial launch of Zeposia (ozanimod) for relapsing multiple sclerosis (RMS). The oral treatment is the first and only approved sphingosine-1-phosphate receptor modulator with no genetic test or first dose observation at initiation.

For individuals with both diabetes and colorectal cancer, high adherence to oral diabetes medication was associated with a significantly reduced risk of overall mortality compared with lower adherence, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.

According to a survey on sleep habits both before and after lockdown measures caused by the coronavirus disease 2019 (COVID-19), 67% of Americans said they believe their sleep was healthier before the pandemic.

Research has established an association between social risk factors and child health outcomes, while professional medical organizations have endorsed screening for such factors in clinical settings. Providing an in-person patient navigator to address family social needs leads to a decrease in child health care utilization, according to a study published in JAMA Network Open.

Those with substance use issues struggle amid the coronavirus disease 2019 (COVID-19) pandemic; health experts cite police brutality as a public health issue; CMS reports COVID-19 death toll in US nursing homes.

As investigators have learned more about how to diagnose and categorize smoldering multiple myeloma (SMM), a new review article argues there’s insufficient data to evolve beyond a close observation approach.

A study released Monday used national Medicare data to try and understand disparities between black and white patients in avoidable hospitalizations for ambulatory care–sensitive conditions.

Strabismus is associated with reduced functional vision and eye-related quality of life (ER-QOL) in children, according to a study published in JAMA Ophthalmology. Because of this, when defining management goals, the association of strabismus with functional and ER-QOL in children should be considered.

Researchers uncovered the amount of variance among interrelated Parkinson disease (PD) motor, neuropsychiatric, and cognitive symptoms, which may improve understanding into the pathophysiology of PD, according to study findings published in Human Brain Mapping.

Insulin out-of-pocket costs remained relatively flat between 2006 and 2017 among privately insured patients, despite increased insulin prices paid by insurers, according to research published in JAMA Internal Medicine.

Between 1997 and 2012, the inpatient burden of migraine cost rapidly increased in the United States, according to a study published in PRS Global Open.

Health officials have concerns as people nationwide participate in mass gatherings to protest the death of George Floyd; Trump cuts US ties with WHO over handling of coronavirus disease 2019 (COVID-19); former FDA commisioner Scott Gottlieb, MD, says addressing racial inequities in COVID-19 transmission and higher death rates could halt the pandemic.

Erin L. Arnold, MD, FACR, of Orthopaedics and Rheumatology of the North Shore in Skokie, IL, discusses evolving treatment strategies and the use of biologic therapies in the management of psoriatic disease.

Debra A. Patt, MD, MPH, MBA, a breast cancer specialist at Texas Oncology is the lead author on the study being presented at ASCO.

Use of biologics to treat psoriasis may impact prevalence of comorbidities like depression and obesity, according to an abstract presented at the Virtual 2020 International Society for Pharmacoeconomics and Outcomes Research meeting.